Skip to content

Comparison of the effectiveness of M D Forte taila (applied inside the uterus) and Kalyanaka kshara (taken orally) in treating uterine fibroids.

Efficacy of M.D Forte Taila uttara vasthi in comparison to Kalyanaka kshra orally in uterine leiomyoma - a randomised clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083844
Enrollment
30
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

None listed

Sponsors

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda College and Hospital Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married female patients of age group 30-45 years with uterine leiomyoma, confirm by USG 2. Uterine leiomyoma of size less than 5cm

Exclusion criteria

Exclusion criteria: Post menopausal women 2. Uterine leiomyoma with secondary changes 3. Malignancy, Adnexal mass 4. Pregnancy and lactation 5. Chronic systemic illness Diabetes Mellitus, Hypertension 6. Uterine prolapse 7. Patients with Hb less than 7g 8. Patients with IUCD

Design outcomes

Primary

MeasureTime frame
Significant reduction in signs and symptoms of Uterine leiomyoma and Improvement in quality of living Timepoint: Baseline, 30 days, 60 days, 120 days

Secondary

MeasureTime frame
Improvement in quality of life by reducing signs and symptoms of Uterine leiomyomaTimepoint: Baseline, 30 days, 60 days, 120 days

Countries

India

Contacts

Public ContactDr Gayathry Viswanath

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda College and Hospital Anchepalya, Kumbalagodu Post. Bangalore

drshweta@sdmayurbangalore.in9535201164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026